Sixth Street Partners Management Company »

Protalix Biotherapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $420k 180k 2.33

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics